Harvard Bioscience, Inc. - Common Stock — États financiers (NASDAQ:HBIO)

Afficher le graphique complet Full chart

Harvard Bioscience, Inc. - Common Stock

Harvard Bioscience is a global developer, manufacturer and marketer of life sciences equipment to support research and drug discovery. It is traded on NASDAQ under the stock symbol HBIO. Headquartered in Holliston, Massachusetts, United States, the company's brands include: Biochrom, BTX, CMA, Data Sciences International, Harvard Apparatus, HEKA, Hugo Sachs Elektronik, KD Scientific, Multi Channel Systems, Panlab, and Warner Instruments. The company has approximately 355 employees, with 216 of those in the USA, and its principal manufacturing facilities are in New Brighton, Minnesota, Holliston, Massachusetts, Reutlingen, Germany, Barcelona, Spain, and March, Germany.

HBIO

Financials

Harvard Bioscience, Inc. - Common Stock

Nouvelles

Alerte résultats : Harvard Bioscience rate le BPA au T1 2026, l’action chute

Le directeur de Harvard Bioscience Snider achète pour 103.603$ d’actions HBIO

Benchmark relève l’objectif de cours d’Harvard Bioscience à 6$

Benchmark raises Harvard Bioscience stock price target to $6 on reverse split

Benchmark réduit l’objectif de cours d’Harvard Bioscience sur fond d’inquiétudes liées au NIH

Benchmark cuts Harvard Bioscience stock price target on NIH concerns

Harvard Bioscience, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:HBIO) 2026-03-13

Harvard Bioscience T4 2025 : marges à un plus haut de 7 trimestres

Harvard Bioscience Q4 2025 slides: margins hit 7-quarter high

Le BPA de Harvard Bioscience a manqué les attentes de 0,10$, le CA a surpassé les prévisions

Harvard Bioscience earnings missed by $0.10, revenue topped estimates

Harvard Bioscience : croissance du chiffre d’affaires au T4 2025